comparemela.com

Latest Breaking News On - Centre national biopharma mission - Page 1 : comparemela.com

Zydus Cadila seeks emergency use authorisation for ZyCoV-D COVID-19 vaccine for 12 years, above

Zydus Cadila seeks emergency use authorisation for ZyCoV-D COVID-19 vaccine for 12 years, above Representational Image NEW DELHI : Pharmaceutical major Zydus Cadila on Thursday applied for Emergency Use Authorisation (EUA) seeking approval from the Drugs Controller General of India (DCGI) for the launch of their ZyCoV-D vaccine for 12 years and above, sources said on Thursday. The vaccine has completed the third phase trial, they added. ZyCoV-D is a DNA Covid vaccine, which carries the genetic code for that part of a virus that triggers the immune system of the body. , It will be the second indigenous COVID-19 vaccine to apply for such authorisation as well as the world’s first DNA vaccine against coronavirus.

Zydus Cadila seeks emergency use approval for Covid vax for 12 years, above

The vaccine has completed the third phase trial, they added. ZyCoV-D is a DNA Covid vaccine, which carries the genetic code for that part of a virus that triggers the immune system of the body. , It will be the second indigenous COVID-19 vaccine to apply for such authorisation as well as the world s first DNA vaccine against coronavirus. Earlier, a government source had said: Zydus Cadila has told the government that it could apply for emergency use authorisation for ZyCoV-D vaccine in the next seven-eight days. Earlier on July 18, Niti Aayog Member (Health) Dr VK Paul had told ANI that Cydus Cadila has enrolled more than 28,000 volunteers for their phase three study.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.